Skip to main content
logo
Evertz Technologies Limited (TSX:ET)
Canada flag Canada · Delayed Price · Currency is CAD
12.05
-0.16 (-1.31%)
Aug 8, 2025, 4:00 PM EDT

Regulus Therapeutics Revenue

In the fiscal year ending April 30, 2025, Evertz Technologies had annual revenue of 501.62M CAD, down -2.52%. Evertz Technologies had revenue of 127.81M in the quarter ending April 30, 2025, with 4.10% growth.

Revenue
501.62M
Revenue Growth
-2.52%
P/S Ratio
1.82
Revenue / Employee
310.22K
Employees
1,617
Market Cap
910.88M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 2025501.62M-12.99M-2.52%
Apr 30, 2024514.62M60.04M13.21%
Apr 30, 2023454.58M13.56M3.08%
Apr 30, 2022441.02M98.13M28.62%
Apr 30, 2021342.89M-93.70M-21.46%
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Constellation Software14.90B
Celestica14.44B
CGI Inc.15.56B
Topicus.com2.25B
Lumine Group991.65M
The Descartes Systems Group923.60M
Kinaxis701.93M
BlackBerry733.46M
Revenue Rankings

Evertz Technologies News

More News